C09980752 / invoice 10000
Species:CANINE
Breed:Rhodesian Ridgeback Cross
Age (years):7
Diagnosis or signs:Mtastatic (stage 3, axillary lymph node) high grade/grade 3 cutaneous mast cell tumour completely excised with narrow margins from the lateral right abdominal wall
Consult notes
Tx 4 VBL TOC
Previous claim history (5)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-01-20 | C09785690 | MAST CELL TUMOUR |
| 2026-01-12 | C09743944 | MAST CELL TUMOUR |
| 2026-01-05 | C09721783 | MAST CELL TUMOUR |
| 2025-12-22 | C09711552 | MAST CELL TUMOUR |
| 2025-12-22 | C09711851 | DENTAL (TOOTH) DISORDER |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_chemotherapy | 132.74 | 2026-03-03 | — |
| 20000 | tstarc_diagnostic_test_-_haematology | 106.19 | 2026-03-03 | — |
| 30000 | tstarc_diagnostic_test_-_blood_test | 22.12 | 2026-03-03 | — |
| 40000 | tstarc_chemotherapy | 106.19 | 2026-03-03 | — |
| 50000 | tstarc_iv_catheterisation | 97.34 | 2026-03-03 | — |
| 60000 | tstarc_disposables | 10.00 | 2026-03-03 | — |
| 70000 | tstarc_consumables | 11.00 | 2026-03-03 | — |
| 80000 | tstarc_consumables | 4.13 | 2026-03-03 | — |
| 90000 | tstarc_syringe | 27.50 | 2026-03-03 | — |
| 100000 | tstarc_chemotherapy | 332.79 | 2026-03-03 | — |
| 110000 | tstarc_anti-nausea_medication | 50.00 | 2026-03-03 | — |
| 120000 | tstarc_anaesthesia_-_monitoring | 83.88 | 2026-03-03 | — |
| 130000 | tstarc_sedation_for_procedure | 10.49 | 2026-03-03 | — |
| 140000 | tstarc_opioids_-_butorphanol | 16.40 | 2026-03-03 | — |
| 150000 | tstarc_sedation_reversal_agent | 9.23 | 2026-03-03 | — |
UPM+
- DG02738MAST CELL TUMOURDSTP_mast_cell_tumour
Variant (sleepy_king)
MAST CELL TUMOUR
DSTP_mast_cell_tumour
Conf: 1.000
Threshold: 0.58
Above: ✓
Correct?